Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Dog study reveals information about human brain tumours
Boxer
Brachycephalic breeds like boxers and bulldogs are at particular risk of developing glioma.

Genome responsible for rare Glioma discovered

Researchers have located genomes in a study into closely linked dog and human brain tumours.

Published in the journal PLOS Genetics,  scientists from Uppsala University and Swedish University of Agricultural Sciences, analysed genes in different dog breeds linked to the development of the rarely curable glioma.

Brachycephalic breeds like boxers and bulldogs are at particular risk of developing glioma. By
identifying a genomic region shared by the breeds, researchers determined that genomic links were likely.

"In our study we hypothesized that since the brachycephalic dog breeds with elevated risk are closely related we would be able to identify a genomic region shared by those breeds," says Katarina Truvé, former doctoral student at the Swedish University of Agricultural Sciences.

She contiued: "The same risk factors for glioma could also be present in other breeds and the way to identify the genomic region would be to compare genetic markers from dogs diagnosed with glioma from several breeds to healthy controls."

Further genetic analyses were performed using 25 different dog breeds and the researchers could identify an area in the genome that differed between diseased and healthy dogs.

Within this genome, three genes were identified as associated with glioma development, which humans also have.  

Karin Forsberg Nilsson, Professor at the Department of Immunology, Genetics and Pathology and Science for Life Laboratory, said: "These results indicate that further investigations of the role of these three genes in glioma development would be of interest, with potential benefit to both dog and human."

 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.